Quent Capital’s Takeda Pharmaceutical TAK Stock Holding History

Quent Capital’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75K	Buy	+109	New	+$1.8K	﹤0.01%	1490
2022 Q4	–	Sell	-20	Closed	–	–	1362
2022 Q3	$0	Hold	20	–	–	﹤0.01%	1277
2022 Q2	$0	Hold	20	–	–	﹤0.01%	1305
2022 Q1	$0	Buy	+20	New	+$294	﹤0.01%	1323

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Quent Capital's TAK Position: Q2 2026 in Review

Quent Capital opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 109 shares worth $1.75K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Quent Capital previously reported a position in TAK as recently as Q3 2022.

Quent Capital first reported a position in TAK in Q1 2022 and has held it in 4 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Quent Capital held 109 shares of Takeda Pharmaceutical worth $1.75K as of Q2 2026.
Takeda Pharmaceutical was a new Quent Capital position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1490 holding.
Quent Capital first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 4 quarters since.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.